Marco Gottardis's most recent trade in NKGen Biotech Inc was a trade of 300,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NKGen Biotech Inc | Marco Gottardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 300,000 | 16,667 | - | - | Stock Option (right to buy) |